On Friday, Nutex Health Inc (NASDAQ: NUTX) was -5.20% drop from the session before settling in for the closing price of $88.39. A 52-week range for NUTX has been $17.51 – $184.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -44.97%. With a float of $3.54 million, this company’s outstanding shares have now reached $5.53 million.
Nutex Health Inc (NUTX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Nutex Health Inc stocks. The insider ownership of Nutex Health Inc is 36.21%, while institutional ownership is 31.59%. The most recent insider transaction that took place on Apr 08 ’25, was worth 81,810. In this transaction Chief Financial Officer of this company bought 1,000 shares at a rate of $81.81, taking the stock ownership to the 4,888 shares.
Nutex Health Inc (NUTX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.15 earnings per share (EPS) during the time that was better than consensus figure (set at -0.29) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.95 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -44.97% per share during the next fiscal year.
Nutex Health Inc (NASDAQ: NUTX) Trading Performance Indicators
You can see what Nutex Health Inc (NUTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.75. Likewise, its price to free cash flow for the trailing twelve months is 6.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.90, a number that is poised to hit 0.62 in the next quarter and is forecasted to reach 11.86 in one year’s time.
Technical Analysis of Nutex Health Inc (NUTX)
Nutex Health Inc (NASDAQ: NUTX) saw its 5-day average volume 0.17 million, a positive change from its year-to-date volume of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 17.38%.
During the past 100 days, Nutex Health Inc’s (NUTX) raw stochastic average was set at 5.45%, which indicates a significant increase from 4.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 9.49 in the past 14 days, which was lower than the 11.81 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $103.17, while its 200-day Moving Average is $82.13. Nevertheless, the first resistance level for the watch stands at $88.19 in the near term. At $92.59, the stock is likely to face the second major resistance level. The third major resistance level sits at $95.19. If the price goes on to break the first support level at $81.19, it is likely to go to the next support level at $78.59. Assuming the price breaks the second support level, the third support level stands at $74.19.
Nutex Health Inc (NASDAQ: NUTX) Key Stats
There are 5,555K outstanding shares of the company, which has a market capitalization of 465.46 million. As of now, sales total 479,950 K while income totals 52,180 K. Its latest quarter income was 211,790 K while its last quarter net income were 14,630 K.
